Inspire Medical Systems(INSP)
$61.10+0.56 (+0.93%)
INSP
Inspire Medical Systems stock drug pipeline
$61.10
At close:+0.56 (+0.93%)
Want to see INSP full AI Analyst Report?
Inspire Medical Systems (INSP) Drug Pipeline
815 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Inspire Upper Airway Stimulation System | Obstructive Sleep Apnea, Down Syndrome | Phase III | Active Not Recruiting | Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea | Dec 15, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Inspire Upper Airway Stimulation System | Phase III | Obstructive Sleep Apnea, Down Syndrome | Active Not Recruiting | Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea | Dec 15, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Inspire Medical (INSP) have in its pipeline
Inspire Medical Systems INSP is currently developing the following drugs: Inspire Upper Airway Stimulation System. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
